Trials / Conditions / Hyperlipoproteinemia Type I
Hyperlipoproteinemia Type I
3 registered clinical trials studyying Hyperlipoproteinemia Type I.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Orlistat for the Treatment of Type I Hyperlipoproteinemia NCT02767531 | University of Texas Southwestern Medical Center | Phase 2 |
| Completed | Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia NCT02098278 | Catabasis Pharmaceuticals | Phase 2 |
| Terminated | Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies NCT01447901 | Amsterdam Molecular Therapeutics | — |